Rocketing Vaccine Cost Warning

Rocketing Vaccine Cost Warning

Rocketing Vaccine Cost Warning

Life-saving vaccines prices rose and left some countries struggling to fully immunize children, MSF warns.

Says a report by the charity was an increase of 68 times in prices between 2001 and 2014.The pharmaceutical industry and accused overload relief where getting rich Western countries rate better than poor countries.The price reflects the cost of manufacturing.The report says that medical charity in prices now "exorbitant" and was "calls into question the sustainability of immunization programs.Document "and a correct shot," says doubling the number of vaccines administered since 2001, but the price has increased even more.In 2001, it costs $ 0.67 (£ 0.44) to vaccinate against tuberculosis, measles, diphtheria, tetanus, pertussis and polio.Since then, rubella, hepatitis B, Haemophilus influenzae type b and pneumococcal disease, rotavirus and HPV has been added (HPV) vaccines for immunization programs.But the cost has risen to $ 45.59 (£ 30.07) for each child.

UnaffordableS
aid Rohit Malpani, MSF: "The price of the child completely immunized is 68 times more expensive than it was little more than a decade, mainly due to the small number of large pharmaceutical companies paid donors and countries in the development of vaccines they earn already billions of dollars in rich countries. Organization highlighted the cost of the vaccine is relatively new pneumococcal, which they say represents 45% of the total cost of the vaccination of children in the poorest countries.Mr. Malpani says it is not necessary to have more transparency about the costs involved in the production of vaccines.The report also mentions the case of hospitals in Morocco are shipped more than one dose of the vaccine France.We believe that it is time that GSK and Pfizer to do their part to make vaccines more affordable for countries in the long term, as the reduction of the companies that offer today is simply not good enough," added Mr. Malpani.Calls MSF on each of the pharmaceutical companies to reduce the price of the vaccine in the US $ 5 (£ 3,30) for each child.

Rocketing Vaccine Cost Warning

The poorest countries have immunization programs supported by the Alliance vaccine Jaffe.The report warns of MSF which is a middle-income countries do not benefit from vaccines.However, he adds that progress means that many countries on the verge of losing the support of the coalition.Angola will happen in the next year, it is expected that the vaccine bill to increase the country's 1,500%.In a statement, Pfizer said the company "proud" said commitments vaccination worldwide.He said: "The price of Prevenar 13 [pneumococcal vaccine] reflects the fact that it is one of the most complex biological product ever developed and manufactured."For example, each of the 13 individual components requires a separate process for purification, conjugation and testing."It takes more than two years to create a batch of Prevenar 13, which covers about 500 separate quality control checks before releasing the product distribution, multiple facilities and hundreds of trained professionals.He GSK: "About 80% of all GSK vaccines, including pneumococcal vaccine we have, and provide developing countries with a significant discount to Western prices.We have a pneumococcal vaccine is one of the most complex that we have made, and the combination of mainly 10 vaccines in one.For countries Jaffe qualified, we offer the vaccine at a very reduced price. At this level, we can only cover our costs.For more discount threaten our ability to provide these countries in the long term. However, we constantly look for ways to reduce production costs and savings to express Jaffe us."